Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Fux

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|October 4, 2003
[Quality of antithrombotic therapy in patients with chronic atrial fibrillation: the AFib Trial]Reinhild Bücheler, Christoph Meisner, Klaus Mörike, et al.
BMC Cancer|April 7, 2009
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selectionCarsten Henneges, Dino Bullinger, Richard Fux, et al.
Journal of Clinical Pharmacology|December 29, 2006
Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitorThomas D Bethke, Gabriele M Böhmer, Robert Hermann, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical studyRichard Fux, Klaus Mörike, Anne M T Pröhmer, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|October 4, 2003
[Quality of antithrombotic therapy in patients with chronic atrial fibrillation: the AFib Trial]Reinhild Bücheler, Christoph Meisner, Klaus Mörike, et al.
BMC Cancer|April 7, 2009
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selectionCarsten Henneges, Dino Bullinger, Richard Fux, et al.
Journal of Clinical Pharmacology|December 29, 2006
Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitorThomas D Bethke, Gabriele M Böhmer, Robert Hermann, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical studyRichard Fux, Klaus Mörike, Anne M T Pröhmer, et al.
Pageof 2